Worsley Stephen 4
4 · SUTRO BIOPHARMA INC · Filed Sep 27, 2018
Insider Transaction Report
Form 4
Worsley Stephen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy Common Stock)
2018-09-26+203,056→ 203,056 totalExercise: $15.00Exp: 2028-09-25→ Common Stock (203,056 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on the one year anniversary of September 10, 2018 and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on September 10, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.